Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

Morgan CJ, Schafer G, Freeman TP, Curran HV.

Br J Psychiatry. 2010 Oct;197(4):285-90. doi: 10.1192/bjp.bp.110.077503. Erratum in: Br J Psychiatry. 2010 Nov;197:416.

PMID:
20884951
[PubMed - indexed for MEDLINE]
Free Article
2.

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.

Morgan CJ, Freeman TP, Schafer GL, Curran HV.

Neuropsychopharmacology. 2010 Aug;35(9):1879-85. doi: 10.1038/npp.2010.58. Epub 2010 Apr 28.

PMID:
20428110
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):68-76. doi: 10.1016/j.drugalcdep.2012.10.011. Epub 2012 Nov 10.

PMID:
23146820
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.

Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.

Brain Res. 2008 Jan 10;1188:157-64. Epub 2007 Oct 12.

PMID:
18021759
[PubMed - indexed for MEDLINE]
5.

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.

Morgan CJ, Gardener C, Schafer G, Swan S, Demarchi C, Freeman TP, Warrington P, Rupasinghe I, Ramoutar A, Tan N, Wingham G, Lewis S, Curran HV.

Psychol Med. 2012 Feb;42(2):391-400. doi: 10.1017/S0033291711001322. Epub 2011 Jul 29.

PMID:
21798112
[PubMed - in process]
6.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.

Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA.

Clin Chem. 2013 Dec;59(12):1770-9. doi: 10.1373/clinchem.2013.207316. Epub 2013 Aug 12.

PMID:
23938457
[PubMed - indexed for MEDLINE]
7.

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.

Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P.

Arch Gen Psychiatry. 2009 Apr;66(4):442-51. doi: 10.1001/archgenpsychiatry.2009.17.

PMID:
19349314
[PubMed - indexed for MEDLINE]
8.

Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.

Wright MJ Jr, Vandewater SA, Taffe MA.

Br J Pharmacol. 2013 Dec;170(7):1365-73. doi: 10.1111/bph.12199.

PMID:
23550724
[PubMed - indexed for MEDLINE]
9.

Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.

Ilan AB, Gevins A, Coleman M, ElSohly MA, de Wit H.

Behav Pharmacol. 2005 Sep;16(5-6):487-96.

PMID:
16148455
[PubMed - indexed for MEDLINE]
10.

Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA.

Clin Chem. 2012 Apr;58(4):748-56. doi: 10.1373/clinchem.2011.177881. Epub 2012 Jan 24.

PMID:
22273566
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.

Morgan CJ, Curran HV.

Br J Psychiatry. 2008 Apr;192(4):306-7. doi: 10.1192/bjp.bp.107.046649.

PMID:
18378995
[PubMed - indexed for MEDLINE]
Free Article
12.

Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.

Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA.

Clin Chem. 2011 Aug;57(8):1127-36. doi: 10.1373/clinchem.2011.164822. Epub 2011 Jun 15.

PMID:
21677094
[PubMed - indexed for MEDLINE]
Free Article
13.

Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.

Roser P, Gallinat J, Weinberg G, Juckel G, Gorynia I, Stadelmann AM.

Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):284-92. doi: 10.1007/s00406-009-0868-5. Epub 2009 Feb 17.

PMID:
19224107
[PubMed - indexed for MEDLINE]
14.

Exposure to marijuana smoke impairs memory retrieval in mice.

Niyuhire F, Varvel SA, Martin BR, Lichtman AH.

J Pharmacol Exp Ther. 2007 Sep;322(3):1067-75. Epub 2007 Jun 22.

PMID:
17586723
[PubMed - indexed for MEDLINE]
Free Article
15.

[Short-and long-term effects of cannabinoids on memory, cognition and mental illness].

Sagie S, Eliasi Y, Livneh I, Bart Y, Monovich E.

Harefuah. 2013 Dec;152(12):737-41, 751. Review. Hebrew.

PMID:
24483000
[PubMed - indexed for MEDLINE]
16.

On-site test for cannabinoids in oral fluid.

Desrosiers NA, Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA.

Clin Chem. 2012 Oct;58(10):1418-25. Epub 2012 Aug 21.

PMID:
22912396
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.

Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S.

J Psychopharmacol. 2013 Jan;27(1):19-27. doi: 10.1177/0269881112460109. Epub 2012 Oct 5.

PMID:
23042808
[PubMed - indexed for MEDLINE]
18.

Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.

D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J.

Neuropsychopharmacology. 2008 Sep;33(10):2505-16. doi: 10.1038/sj.npp.1301643. Epub 2008 Jan 9.

PMID:
18185500
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Hunault CC, Mensinga TT, Böcker KB, Schipper CM, Kruidenier M, Leenders ME, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2009 May;204(1):85-94. doi: 10.1007/s00213-008-1440-0. Epub 2008 Dec 20.

PMID:
19099294
[PubMed - indexed for MEDLINE]
20.

Heterogeneity in the composition of marijuana seized in California.

Burgdorf JR, Kilmer B, Pacula RL.

Drug Alcohol Depend. 2011 Aug 1;117(1):59-61. doi: 10.1016/j.drugalcdep.2010.11.031. Epub 2011 Feb 1.

PMID:
21288662
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk